CN1120014C - Chinese patent medicine for treating hyperosteogeny - Google Patents

Chinese patent medicine for treating hyperosteogeny Download PDF

Info

Publication number
CN1120014C
CN1120014C CN01141086A CN01141086A CN1120014C CN 1120014 C CN1120014 C CN 1120014C CN 01141086 A CN01141086 A CN 01141086A CN 01141086 A CN01141086 A CN 01141086A CN 1120014 C CN1120014 C CN 1120014C
Authority
CN
China
Prior art keywords
parts
medicine
chinese patent
patent medicine
chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN01141086A
Other languages
Chinese (zh)
Other versions
CN1346673A (en
Inventor
王振林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN01141086A priority Critical patent/CN1120014C/en
Publication of CN1346673A publication Critical patent/CN1346673A/en
Application granted granted Critical
Publication of CN1120014C publication Critical patent/CN1120014C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention discloses medicinal powder of Chinese patent medicine for external application for treating hyperosteogeny, which is characterized in that 14 kinds of Chinese herbal medicines such as musk, borneol, common clubmoss herb, garden balsam stem, common selfheal fruit-spike, caulis impatientis balsaminae, raw common monkshood mother root, raw kusnezoff monkshood root, sodium sulfate, smoked plum pulp, raw hawthorn pulp, Chinese honeylocust spine, frankincense, myrrh, etc., are prepared into medicinal powder of Chinese patent medicine for external application. The present invention has the functions of warming and dredging collaterals, activating blood circulation, dissipating blood stasis, softening osteophyte, alleviating edema and relieving pain, which conform to the pathogenesis of the disease. When used, the present invention has safety, reliability and lasting potency of medicine, and the clinical effective rate can reach 95.9%, so the present invention is a Chinese patent medicine which is worth popularizing.

Description

A kind of Chinese patent medicine for the treatment of hyperosteogeny
One, technical field
The present invention relates to a kind of medicine for the treatment of hyperosteogeny, relate in particular to a kind of external Chinese patent medicine for the treatment of hyperosteogeny.
Two, background technology
Hyperosteogeny is a kind of commonly encountered diseases, be commonly called as " bony spur ", the category that belongs to the traditional Chinese medical science " rheumatism involving the bone ", cardinal symptom is that the disease sites activity is obviously limited, moving then pain increases the weight of, sometimes the obvious spasm atrophy of muscle, rise morning or have a humid climate, the state of an illness increases the weight of when cold, cervical spondylosis patient is sometimes also with symptoms such as headache, dizziness, blurred vision, numb limbs and tense tendons, the severe patient mobility goes down greatly, amyotrophy and positional vertigo etc. occur, thereby had a strong impact on patient's work, studying and living, have in addition lost work capacity.
Doctor trained in Western medicine does not have specific short to primary disease, except that severe patient is used the operation, generally imports with physical therapy and electron ion, and the hyperosteogeny patient is then used traction treatment, and its uncertain therapeutic efficacy is cut, easily recurrence.The traditional Chinese medical science also has a lot of Therapeutic Method to this disease, and is each has something to recommend him, but curative effect all is not to make us feeling quite pleased.
Three, summary of the invention
The Chinese patent medicine that the purpose of this invention is to provide the treatment hyperosteogeny that a kind of efficacy of a drug is strong, effective percentage is high and have no side effect.
The solution that realizes above-mentioned purpose is based on motherland's medical science to pathogenetic understanding of hyperosteogeny and Therapeutic Principle, again through clinical research for many years, draw the experience of doctor family treatment hyperosteogeny at all times, from motherland's medicine treasure-house, filter out the Chinese herbal medicine of temperature three-way meridian, blood circulation promoting and blood stasis dispelling, softening bony spur, reducing swelling and alleviating pain, by traditional Chinese medical science prescription theory, skim the cream off milk, be prepared into the external Chinese patent medicine.
The traditional Chinese medical science claims that hyperosteogeny is " arthromyodynia ", and site of pathological change relates to cervical vertebra, lumbar vertebra, elbow joint, knee joint, calcaneus etc., though its site of pathological change difference, its cause of disease has general character, all owing to wind, cold, wet due to.The present invention is the prescription foundation with " temperature three-way meridian, blood circulation promoting and blood stasis dispelling, softening bony spur, reducing swelling and alleviating pain ", meets the pathogeny of primary disease.
The raw material of Chinese medicine of Chinese patent medicine of the present invention and weight proportion are:
Moschus 0.3-1 part Borneolum Syntheticum 3-5 part Herba Lycopodii 3-5 part
Herba speranskiae tuberculatae 3-5 part Spica Prunellae 3-5 part FENGXIANCAO 3-5 part
Radix Aconiti 2-4 part Radix Aconiti Kusnezoffii 2-4 part Natrii Sulfas 3-15 part
Fructus Mume 5-10 part Fructus Crataegi meat 5-10 part Spina Gleditsiae 3-5 part
Olibanum 3-5 part Myrrha 3-10 part
Above-mentioned Chinese medicine raw materials by weight proportion is made the external pulvis Chinese patent medicine.
The optimum weight proportioning of Chinese patent medicine raw material of Chinese medicine of the present invention is:
4 parts of 4 parts of Herba Lycopodiis of 0.6 part of Borneolum Syntheticum of Moschus
4 parts of 4 parts of FENGXIANCAO of 4 parts of Spica Prunellaes of Herba speranskiae tuberculatae
9 parts in 3 parts of Natrii Sulfas of 3 parts of Radix Aconiti Kusnezoffii of Radix Aconiti
4 parts of 8 parts of Spina Gleditsiaes of 8 portions of Fructus Crataegi meat of Fructus Mume
7 parts of 4 parts of Myrrhas of Olibanum
Pharmacology analysis:
Moschus, Borneolum Syntheticum promoting blood circulation to remove obstruction in the collateral, reducing swelling and alleviating pain, it is strong to get the fragrant virtue of its flavor, and headed by the product Moschus, inducting the medicines into affected channel is commanded all medicines, cuts Guan Benmen on the consciousness restoring, directes reach the disease position; Herba Lycopodii, Herba speranskiae tuberculatae, FENGXIANCAO, Spica Prunellae expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation and stopping pain; Radix Aconiti, Radix Aconiti Kusnezoffii, Natrii Sulfas wind-damp dispelling, antalgic; Fructus Mume, Fructus Crataegi meat, Spina Gleditsiae promoting QI to circulate and dispersing the agglomeration of the pathogens, softening the hard mass pain relieving, blood sugar lowering; Olibanum, Myrrha blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain.
Above-mentioned each medicine closes and uses it, plays the merit of " temperature three-way meridian, blood circulation promoting and blood stasis dispelling, softening bony spur, reducing swelling and alleviating pain " altogether.
Processing of medical material:
Said medicine is parched and refine medicinal herbs respectively, concentrates, processed carefully and grind, and mix homogeneously divides pack standby.
Using method:
Every bag of medicated powder is to measure in a week, get one jin of pig scrap, one jin in mature vinegar is respectively got half with iron filings and medicine, mix well (cloth being bedewed degree of being with four spoonfuls of old vinegars, can not be too much, in order to avoid lost efficacy), make a pocket with black coarse cloth, be about 15cm, wide about 10cm, with mix up medicine mud pack in the bag, spread on affected part and get final product.Night, hora somni(hs) applied, and took off sealing after getting up morning.Again the bag giving drugs into nose was poured out to smash to pieces in second day and add four spoonfuls of vinegar and pack into and continue an application in the bag, logotype got final product in three days, and remaining medicated powder and iron filings logotype again got final product in three days.Be a course of treatment January, and a general case symptom course of treatment can be alleviated or complete obiteration.Just can recover normal three courses of treatment.
This medicine treating hyperosteogeny, intervertebral disk hernia, ankylosing spondylitis, rheumatism etc.
The external application therapy is in the existing long history of China.As far back as the famous physician's Xu Dachun of the Qing Dynasty praise cream, the medicine that looses says: " if it sick existingly decide institute, between skin muscles and bones can by and the person, with cream, loose plaster it; inaccessible its gas; the property of medicine is gone in the natural fibre line of meat from pore, stimulate the menstrual flow and pass through network or the power of carrying goes out it, take medicine especially effectively ".When medicine looses when being closed in diseased region, promptly produce steam, the property of medicine is directly infiltrated in the natural fibre line of meat from local skin pore or acupuncture point, connect the meridians blood vessels.Application time is long because medicine looses, put the property of medicine continue also of a specified duration, thereby played the meridian dredging, qi and blood circulation promotion, moisten the effect of muscles and bones.Words with doctor trained in Western medicine are said, the diffusing external application of medicine can make local vascular dilation, the blood and the lymph circulation at hypertrophy position have been promoted, improved the nutritional status of local bone tissue, amyotrophy is improved, remove spasm, adhesion, the swelling of soft tissue, quickened the absorption of inflammation, edema and pathological changes product, promoted to be compromised the reparation of tissue.By to each position bone matrix hyperplasia, intervertebral disk hernia, ankylosing spondylitis, rheumatismal clinical observation, this medicine of external application is dispersed in the articular cartilage face of having repaired wearing and tearing to a certain extent, make the sclerotin of distortion be tending towards normal, the bony spur atrophy is shortened, the blood stasis that intervertebral disk hernia is formed, edema, inflammation and oppressed nerve are eased, the muscle ligament tense situation is relaxed, thereby intervertebral disc is bounced back naturally, reached the effect of relieving spasm to stop pain preferably, alleviated bony spur greatly, intervertebral disk hernia, ankylosing spondylitis, the local pain that rheumatism caused, limitation of activity, the functional activity in distortion joint recovers normal, reaches the purpose of healing.
Be the clinical efficacy statistics of 150 routine hyperosteogeny patients being treated below with Chinese patent medicine of the present invention.
Criterion of therapeutical effect:
Recovery from illness: (1) clinical symptom disappearance;
(2) joint function recovery;
(3) the X line is checked the hypertrophy atresia or is attenuated and diminishes.
Take a turn for the better: (1) clinical symptom relief;
(2) function of joint is partly recovered, and can be engaged in light physical labor;
(3) X line check, no significant change.
Invalid: in three weeks of clinical application, symptom, sign, X line are checked as before.
Therapeutic outcome:
Diseased region Case load Recovery from illness Take a turn for the better Invalid
The example number The example number The example number
Cervical vertebra 29 26 89.8 2 7 1 3.15
Lumbar vertebra 41 31 75.6 8 19.5 2 4.9
Calcaneus 45 39 86.6 4 11.1 2 2.3
Elbow joint 9 7 77.7 2 22.3 / /
Knee joint 26 22 84.6 3 11.5 1 3.9
Add up to 150 125 83.3 19 12.6 6 4.1
By above statistics as can be known, above-mentioned 150 routine hyperosteogeny patients loose with medicine of the present invention, and total effective rate is 95.9% behind the external application for curing.
The diffusing clinical use result of medicine of the present invention shows that following advantage is arranged:
Bony spur disease, intervertebral disk hernia, ankylosing spondylitis, rheumatism belong to traditional Chinese medical science deficiency in origin and excess in superficiality, but medicine of the present invention looses external application both kidney tonifying effect a permanent cure, but also promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling, softening bony spur, expelling wind and cold, strengthening vital QI to eliminate pathogenic factors, treating both the principal and the secondary aspects of a disease at the same time, demonstrate fully differential diagnosis in tcm and executed the speciality of controlling, application compress are loose treatment conveniently, are easy to accept, and are evident in efficacy.
Four, the specific embodiment
Embodiment 1, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is:
Moschus 0.6g Borneolum Syntheticum 4g Herba Lycopodii 4g
Herba speranskiae tuberculatae 4g Spica Prunellae 4g FENGXIANCAO 4g
Radix Aconiti 3g Radix Aconiti Kusnezoffii 3g Natrii Sulfas 9g
Fructus Mume 8g Fructus Crataegi meat 8g Spina Gleditsiae 4g
Olibanum 4g Myrrha 7g
Method for making: said medicine is parched and refine medicinal herbs respectively, concentrates, processed carefully and grind, mix homogeneously, the medicated bag of packing into gets final product.
Embodiment 2, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is:
Moschus 0.3g Borneolum Syntheticum 3g Herba Lycopodii 3g
Herba speranskiae tuberculatae 3g Spica Prunellae 3g FENGXIANCAO 3g
Radix Aconiti 2g Radix Aconiti Kusnezoffii 2g Natrii Sulfas 3g
Fructus Mume 5g Fructus Crataegi meat 5g Spina Gleditsiae 3g
Olibanum 3g Myrrha 3g
Above-mentioned Chinese medicine raw materials by weight proportion is made the external pulvis Chinese patent medicine.
Embodiment 3, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is:
Moschus 1g Borneolum Syntheticum 5g Herba Lycopodii 5g
Herba speranskiae tuberculatae 5g Spica Prunellae 5g FENGXIANCAO 5g
Radix Aconiti 4g Radix Aconiti Kusnezoffii 4g Natrii Sulfas 15g
Fructus Mume 10g Fructus Crataegi meat 10g Spina Gleditsiae 5g
Olibanum 5g Myrrha 10g
Above-mentioned Chinese medicine raw materials by weight proportion is made the external pulvis Chinese patent medicine.

Claims (2)

1, a kind of Chinese patent medicine for the treatment of hyperosteogeny, it is characterized in that: the raw material of Chinese medicine of Chinese patent medicine of the present invention and weight proportion are:
Moschus 0.3-1 part Borneolum Syntheticum 3-5 part Herba Lycopodii 3-5 part
Herba speranskiae tuberculatae 3-5 part Spica Prunellae 3-5 part FENGXIANCAO 3-5 part
Radix Aconiti 2-4 part Radix Aconiti Kusnezoffii 2-4 part Natrii Sulfas 3-15 part
Fructus Mume 5-10 part Fructus Crataegi meat 5-10 part Spina Gleditsiae 3-5 part
Olibanum 3-5 part Myrrha 3-10 part
Above-mentioned Chinese medicine raw materials by weight proportion is made the external pulvis Chinese patent medicine.
2, the Chinese patent medicine of treatment hyperosteogeny according to claim 1 is characterized in that: the weight proportion of described raw material of Chinese medicine is:
4 parts of 4 parts of Herba Lycopodiis of 0.6 part of Borneolum Syntheticum of Moschus
4 parts of 4 parts of FENGXIANCAO of 4 parts of Spica Prunellaes of Herba speranskiae tuberculatae
9 parts in 3 parts of Natrii Sulfas of 3 parts of Radix Aconiti Kusnezoffii of Radix Aconiti
4 parts of 8 parts of Spina Gleditsiaes of 8 portions of Fructus Crataegi meat of Fructus Mume
7 parts of 4 parts of Myrrhas of Olibanum
Above-mentioned Chinese medicine raw materials by weight proportion is made the external pulvis Chinese patent medicine.
CN01141086A 2001-09-29 2001-09-29 Chinese patent medicine for treating hyperosteogeny Expired - Fee Related CN1120014C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN01141086A CN1120014C (en) 2001-09-29 2001-09-29 Chinese patent medicine for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN01141086A CN1120014C (en) 2001-09-29 2001-09-29 Chinese patent medicine for treating hyperosteogeny

Publications (2)

Publication Number Publication Date
CN1346673A CN1346673A (en) 2002-05-01
CN1120014C true CN1120014C (en) 2003-09-03

Family

ID=4676050

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01141086A Expired - Fee Related CN1120014C (en) 2001-09-29 2001-09-29 Chinese patent medicine for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN1120014C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102895480A (en) * 2012-11-07 2013-01-30 崔聪聪 Chinese medicine for treating bone spur

Also Published As

Publication number Publication date
CN1346673A (en) 2002-05-01

Similar Documents

Publication Publication Date Title
CN104189871A (en) Medicated wine for treating osteoproliferation
CN103006962A (en) Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation
CN101234153B (en) Externally-applied medicament for treating bone fracture
CN103690623B (en) Medicated wine for treating traumatic injury
CN101185672B (en) Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny
CN100534480C (en) Bone-setting medicine and preparation method thereof
CN1069527C (en) Medicine for hyperosteogeny and wind-cold syndrome
CN106985719A (en) A kind of Chinese medicine car pillow for preventing and treating cervical spondylopathy
CN1555857A (en) Medicinal plaster for treating sinew and bone tissue injury pain, bone fracture, dislocation
CN102526482A (en) Traditional Chinese medicine preparation for treating lumbar disc herniation
CN1120014C (en) Chinese patent medicine for treating hyperosteogeny
CN104055973B (en) Treatment rheumatism bone disease, the Chinese medicinal liniment of arthralgia
CN102406870A (en) Medicament for treating rheumatic arthralgia
CN1214813C (en) Vulnerary for treating fracture
CN105233265A (en) Composition capable of promoting wound healing
CN1141955C (en) Bi-syndrome treating Chinese medicine preparation
CN111358915A (en) Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof
CN104383175A (en) Medicine for treating chronic osteomyelitis and preparation method of medicine
CN1270833A (en) Bone fracture setting medicine powder
CN1723933A (en) Traditional Chinese medicine capsule for treating application, and its prodn. method
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN115779055A (en) Traditional Chinese medicine composition for treating closed soft tissue injury or degenerative osteoarthritis and application thereof
CN1115160C (en) Orally-applied medicine for treating hyperosteogeny
CN1209156C (en) Medicinal wine for curing old injury recurrent pain
CN1224409C (en) Medicinal wine for treating prolapse of lumbar intervertebral disc

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030903

Termination date: 20091029